These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 12442390)

  • 1. [Fas antigen expression and apoptosis in liver tissues of patients with chronic hepatitis B].
    Mochizuki K; Hayashi N; Hiramatsu N; Kamada T
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):228-33. PubMed ID: 12442390
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C.
    Hiramatsu N; Hayashi N; Katayama K; Mochizuki K; Kawanishi Y; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1994 Jun; 19(6):1354-9. PubMed ID: 7514559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The concentration of Fas in the serum and liver tissue in viral chronic hepatitis B patients treated with lamivudine.
    Lapinski TW
    Hepatogastroenterology; 2005; 52(62):575-9. PubMed ID: 15816481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Fas antigen on hepatocytes in viral hepatitis patients.
    Sekine K; Nishimaki T; Suzuki T; Kasukawa R
    Fukushima J Med Sci; 1997 Jun; 43(1):51-9. PubMed ID: 9431784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical observation of Fas in the liver of chronic hepatitis B and its ultrastructural localization].
    Takatani M; Yamada G
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):234-40. PubMed ID: 12442391
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunohistochemical detection of Fas and apoptosis in type-1 autoimmune hepatitis.
    Seki S; Kitada T; Iwai S; Kadoya H; Yamada T; Kawada N; Sakaguchi H; Wakasa K
    Hepatogastroenterology; 2003; 50(53):1274-7. PubMed ID: 14571717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
    El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
    APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the fas system in hepatitis C virus recurrence after liver transplantation.
    Crespo J; Rivero M; Mayorga M; Fabrega E; Casafont F; Gomez-Fleitas M; Pons-Romero F
    Liver Transpl; 2000 Sep; 6(5):562-9. PubMed ID: 10980054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
    Bortolami M; Kotsafti A; Cardin R; Farinati F
    J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Fas ligand by hepatic macrophages in patients with fulminant hepatic failure.
    Mita A; Hashikura Y; Tagawa Y; Nakayama J; Kawakubo M; Miyagawa S
    Am J Gastroenterol; 2005 Nov; 100(11):2551-9. PubMed ID: 16279913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of in vivo blockade of Fas- and TNFR1-mediated hepatocyte apoptosis by the hepatitis C virus.
    Rubbia-Brandt L; Taylor S; Gindre P; Quadri R; Abid K; Spahr L; Negro F
    J Pathol; 2002 Aug; 197(5):617-23. PubMed ID: 12210081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical study of Fas ligand in liver tissue of chronic hepatitis B virus infection].
    Hu J; Zhang L; Wang H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):64-6. PubMed ID: 12515176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas-mediated apoptosis in acute alcoholic hepatitis.
    Tagami A; Ohnishi H; Moriwaki H; Phillips M; Hughes RD
    Hepatogastroenterology; 2003; 50(50):443-8. PubMed ID: 12749243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hepatitis B and hepatocarcinogenesis: does prevention of "collateral damage" bring the cure?
    Manigold T; Rehermann B
    Hepatology; 2003 Mar; 37(3):707-10. PubMed ID: 12627596
    [No Abstract]   [Full Text] [Related]  

  • 15. Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C.
    Wedemeyer I; Bechmann LP; Odenthal M; Jochum C; Marquitan G; Drebber U; Gerken G; Gieseler RK; Dienes HP; Canbay A
    J Hepatol; 2009 Jan; 50(1):140-9. PubMed ID: 19019483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative correlation between intrahepatic expression of hepatitis C antigens and apoptosis despite high-level expression of Fas and HLA antigens.
    Caronia S; McGarvey MJ; Goldin RD; Foster GR
    J Viral Hepat; 2004 Nov; 11(6):511-8. PubMed ID: 15500551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues.
    Higaki K; Yano H; Kojiro M
    Am J Pathol; 1996 Aug; 149(2):429-37. PubMed ID: 8701982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association among Fas expression in leucocytes, serum Fas and Fas-ligand concentrations and hepatic inflammation and fibrosis in chronic hepatitis C.
    Panasiuk A; Parfieniuk A; Zak J; Flisiak R
    Liver Int; 2010 Mar; 30(3):472-8. PubMed ID: 19919570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection.
    Macias J; Japón MA; Sáez C; Palacios RB; Mira JA; García-García JA; Merchante N; Vergara S; Lozano F; Gómez-Mateos J; Pineda JA
    J Infect Dis; 2005 Nov; 192(9):1566-76. PubMed ID: 16206071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver tissue expression of CD80 and CD95 antigens in chronic hepatitis C: relationship with biological and histological disease activities.
    Fiore G; Piazzolla G; Galetta V; Caccetta L; Schiraldi O; Antonaci S
    Microbios; 1999; 97(386):29-38. PubMed ID: 10413866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.